Reaffirms FY26 Adjusted EBITDA View of $15M-$17M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 08 2026
0mins
Reaffirms FY26 Adjusted EBITDA view $15M-$17M.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AIRS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AIRS
About AIRS
AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
AirSculpt Technologies Q1 2026 Earnings Call Insights
- Revenue Stability: AirSculpt reported Q1 2026 revenue of $39.4 million, flat year-over-year and up 1% on a same-store basis, indicating a gradual recovery after a 16% decline, suggesting that the company's market strategies are beginning to yield results.
- Financial Health Improvement: The company ended the quarter with over $16 million in cash and reduced leverage to below 2.5x, indicating ongoing financial health improvements that provide greater flexibility for future investments and expansions.
- New Service Potential: CEO Jashnani noted that over 150 skin excision procedures were completed in Q1, with new GLP-1-adjacent procedures expected to unlock more than $100 million in long-term revenue potential across existing centers, highlighting the strategic significance of new business lines.
- Enhanced Marketing Strategy: CFO Arthur emphasized an increase in marketing investment to approximately $22.6 million, which raised spending by $800,000, yet is aimed at driving sales growth, indicating the company's strategy to enhance customer acquisition efficiency in a competitive market.
See More
AirSculpt Technologies Reports Q1 Earnings and 2026 Guidance
- Earnings Performance: AirSculpt Technologies reported a Q1 GAAP EPS of -$0.03, aligning with expectations, indicating stability in profitability amidst market challenges.
- Revenue Insights: The company achieved revenue of $39.4 million for the quarter, flat year-over-year, but exceeding market expectations by $0.17 million, reflecting resilience in sales performance.
- Future Guidance: AirSculpt affirmed its 2026 revenue guidance of approximately $151 million to $157 million, with adjusted EBITDA projected between $15 million and $17 million, showcasing confidence in future growth prospects.
- Financial Health: The company aims to maintain net debt leverage below 2.5x, highlighting a commitment to financial stability while pursuing business expansion.
See More
AirSculpt Reports Solid Q1 Results with Revenue Stabilization
- Stable Performance: In Q1 2026, AirSculpt reported a case volume of 3,082, reflecting a slight 0.2% increase from 3,076 in Q1 2025, indicating the company's resilience and sustained market appeal, which bolsters investor confidence.
- Flat Revenue: The revenue for the first quarter stood at $39.4 million, unchanged from the same period in 2025, but increased by 1% on a same-center sales basis, demonstrating positive progress in enhancing customer experience and sales strategies.
- Reduced Net Loss: The net loss for the quarter was $2.4 million, an improvement from $2.8 million in Q1 2025, reflecting ongoing efforts in cost control and operational efficiency, which enhances expectations for future profitability.
- Optimistic Financial Outlook: AirSculpt affirmed its full-year 2026 revenue guidance of approximately $151 to $157 million and adjusted EBITDA guidance of $15 to $17 million, showcasing the company's confidence in future growth and the effectiveness of its strategic planning.
See More
AirSculpt Technologies Updates 2025 Financial Results
- Performance Decline: In Q4 2025, case volume dropped to 2,604, a 15.0% decrease from 3,064 in Q4 2024, indicating a weakening customer demand amid intensified market competition, which led to a 14.6% revenue decline to $33.4 million, adversely affecting the company's financial health.
- Increased Net Loss: The full-year net loss for 2025 was $11.7 million, up from $8.0 million in 2024, highlighting the challenges the company faces in improving profitability amidst strategic adjustments and changing market conditions, which could undermine investor confidence.
- Declining Adjusted EBITDA: Adjusted EBITDA for 2025 was $12.5 million, a 40.5% decrease from $21.0 million in 2024, indicating pressure on cost control and operational efficiency, which may impact future capital investments and expansion plans.
- 2026 Outlook: The company projects 2026 revenue between $151 million and $157 million, with adjusted EBITDA of $15 million to $17 million; while the outlook appears cautiously optimistic, the actual impact will depend on the pace of market recovery and its effects on the company's finances.
See More
AirSculpt Technologies Q4 Earnings Analysis
- Disappointing Earnings: AirSculpt Technologies reported a Q4 non-GAAP EPS of -$0.02 with revenues of $33.4 million, reflecting a 14.8% year-over-year decline and missing expectations by $5.5 million, indicating pressure in market competition.
- 2026 Outlook: The company anticipates 2026 revenues between $151 million and $157 million, slightly below the consensus estimate of $153.5 million, reflecting a cautious stance on future growth, with adjusted EBITDA projected at approximately $15 million to $17 million.
- Debt Leverage Target: AirSculpt aims to maintain net debt leverage below 2.5x, a strategic move designed to enhance financial flexibility and reduce risk, supporting future business expansion efforts.
- Market Reaction Analysis: Despite the disappointing financial performance, the company's low valuation may present a buying opportunity for investors, highlighting market interest in its long-term potential.
See More
AirSculpt Reports Q4 Revenue Decline Amid Strategic Changes
- Revenue Decline: AirSculpt Technologies Inc reported Q4 revenue of $33.4 million, down approximately 15% year-over-year, reflecting challenges in case volume that may impact future market performance.
- Same-Store Sales Drop: Same-store revenue fell by 16% in Q4, indicating difficulties in maintaining consistent sales across existing locations, which could lead to customer attrition and further market share contraction.
- Debt Reduction and Cash Flow: The company paid down $19 million of debt in 2025, ending the year with $56 million in gross debt and $3.1 million in cash flow, although significantly lower than the previous year, it shows ongoing efforts to improve financial health.
- 2026 Outlook: The revenue outlook for 2026 is expected to range from $151 million to $157 million, with adjusted EBITDA projected between $15 million and $17 million, indicating cautious optimism for future growth despite short-term challenges.
See More
AirSculpt Technologies Q1 2026 Earnings Call Insights
- Revenue Stability: AirSculpt reported Q1 2026 revenue of $39.4 million, flat year-over-year and up 1% on a same-store basis, indicating a gradual recovery after a 16% decline, suggesting that the company's market strategies are beginning to yield results.
- Financial Health Improvement: The company ended the quarter with over $16 million in cash and reduced leverage to below 2.5x, indicating ongoing financial health improvements that provide greater flexibility for future investments and expansions.
- New Service Potential: CEO Jashnani noted that over 150 skin excision procedures were completed in Q1, with new GLP-1-adjacent procedures expected to unlock more than $100 million in long-term revenue potential across existing centers, highlighting the strategic significance of new business lines.
- Enhanced Marketing Strategy: CFO Arthur emphasized an increase in marketing investment to approximately $22.6 million, which raised spending by $800,000, yet is aimed at driving sales growth, indicating the company's strategy to enhance customer acquisition efficiency in a competitive market.
See More
AirSculpt Technologies Reports Q1 Earnings and 2026 Guidance
- Earnings Performance: AirSculpt Technologies reported a Q1 GAAP EPS of -$0.03, aligning with expectations, indicating stability in profitability amidst market challenges.
- Revenue Insights: The company achieved revenue of $39.4 million for the quarter, flat year-over-year, but exceeding market expectations by $0.17 million, reflecting resilience in sales performance.
- Future Guidance: AirSculpt affirmed its 2026 revenue guidance of approximately $151 million to $157 million, with adjusted EBITDA projected between $15 million and $17 million, showcasing confidence in future growth prospects.
- Financial Health: The company aims to maintain net debt leverage below 2.5x, highlighting a commitment to financial stability while pursuing business expansion.
See More
AirSculpt Reports Solid Q1 Results with Revenue Stabilization
- Stable Performance: In Q1 2026, AirSculpt reported a case volume of 3,082, reflecting a slight 0.2% increase from 3,076 in Q1 2025, indicating the company's resilience and sustained market appeal, which bolsters investor confidence.
- Flat Revenue: The revenue for the first quarter stood at $39.4 million, unchanged from the same period in 2025, but increased by 1% on a same-center sales basis, demonstrating positive progress in enhancing customer experience and sales strategies.
- Reduced Net Loss: The net loss for the quarter was $2.4 million, an improvement from $2.8 million in Q1 2025, reflecting ongoing efforts in cost control and operational efficiency, which enhances expectations for future profitability.
- Optimistic Financial Outlook: AirSculpt affirmed its full-year 2026 revenue guidance of approximately $151 to $157 million and adjusted EBITDA guidance of $15 to $17 million, showcasing the company's confidence in future growth and the effectiveness of its strategic planning.
See More
AirSculpt Technologies Updates 2025 Financial Results
- Performance Decline: In Q4 2025, case volume dropped to 2,604, a 15.0% decrease from 3,064 in Q4 2024, indicating a weakening customer demand amid intensified market competition, which led to a 14.6% revenue decline to $33.4 million, adversely affecting the company's financial health.
- Increased Net Loss: The full-year net loss for 2025 was $11.7 million, up from $8.0 million in 2024, highlighting the challenges the company faces in improving profitability amidst strategic adjustments and changing market conditions, which could undermine investor confidence.
- Declining Adjusted EBITDA: Adjusted EBITDA for 2025 was $12.5 million, a 40.5% decrease from $21.0 million in 2024, indicating pressure on cost control and operational efficiency, which may impact future capital investments and expansion plans.
- 2026 Outlook: The company projects 2026 revenue between $151 million and $157 million, with adjusted EBITDA of $15 million to $17 million; while the outlook appears cautiously optimistic, the actual impact will depend on the pace of market recovery and its effects on the company's finances.
See More
AirSculpt Technologies Q4 Earnings Analysis
- Disappointing Earnings: AirSculpt Technologies reported a Q4 non-GAAP EPS of -$0.02 with revenues of $33.4 million, reflecting a 14.8% year-over-year decline and missing expectations by $5.5 million, indicating pressure in market competition.
- 2026 Outlook: The company anticipates 2026 revenues between $151 million and $157 million, slightly below the consensus estimate of $153.5 million, reflecting a cautious stance on future growth, with adjusted EBITDA projected at approximately $15 million to $17 million.
- Debt Leverage Target: AirSculpt aims to maintain net debt leverage below 2.5x, a strategic move designed to enhance financial flexibility and reduce risk, supporting future business expansion efforts.
- Market Reaction Analysis: Despite the disappointing financial performance, the company's low valuation may present a buying opportunity for investors, highlighting market interest in its long-term potential.
See More
AirSculpt Reports Q4 Revenue Decline Amid Strategic Changes
- Revenue Decline: AirSculpt Technologies Inc reported Q4 revenue of $33.4 million, down approximately 15% year-over-year, reflecting challenges in case volume that may impact future market performance.
- Same-Store Sales Drop: Same-store revenue fell by 16% in Q4, indicating difficulties in maintaining consistent sales across existing locations, which could lead to customer attrition and further market share contraction.
- Debt Reduction and Cash Flow: The company paid down $19 million of debt in 2025, ending the year with $56 million in gross debt and $3.1 million in cash flow, although significantly lower than the previous year, it shows ongoing efforts to improve financial health.
- 2026 Outlook: The revenue outlook for 2026 is expected to range from $151 million to $157 million, with adjusted EBITDA projected between $15 million and $17 million, indicating cautious optimism for future growth despite short-term challenges.
See More
